The Valley Desk

ArticleACS infectious diseasesPublished

Allosteric Crosstalk between Inhibitor Binding Sites Drives Enhanced Islatravir Susceptibility in F227C HIV-1 Reverse Transcriptase

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source

Institution
Merck & Co.

Publication record

Type
Article
Venue
ACS infectious diseases
Published
Subject terms
Humans; HIV-1; Triazoles; Pyridones; Reverse Transcriptase Inhibitors; Anti-HIV Agents; Cryoelectron Microscopy; Drug Resistance, Viral; Allosteric Regulation; Binding Sites; Models, Molecular; HIV Reverse Transcriptase
PubMed ID
42725963
Added to directory
Source checked

Report a correction or request removal